Judith A Galario, MD
Family Practice · Milpitas
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Galario’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A116162 · Current
Licensed to practise in California · since 2011 · expires 2027-03-31 · University of Hawaii School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Medicaid work
$465,242 in 2024
Medicaid paid $465,242 for 9,888 billed services this clinician did in 2024, up to 120 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 917 | $463,178 |
| Return visit (30+ min) | 652 | $645 |
| Short return visit (20+ min) | 775 | $429 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 60 | $325 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 130 | $107 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 130 | $106 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 12 | $91 |
| Blood test, lipids (cholesterol and triglycerides) | 117 | $75 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 320 | $58 |
| Infectious agent antigen detection by immunoassay technique (eg, enzyme immunoassay [EIA], enzyme-linked immunosorbent assay [ELISA], fluorescence immunoassay [FIA], immunochemiluminometric assay [IMCA]), qualitative or semiquantitative; HIV-1 antigen(s), with HIV-1 and HIV-2 antibodies, single result | 67 | $53 |
| COMPREHENSIVE METABOLIC PANEL | 63 | $36 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 14 | $35 |
| 2024 | 9,888 | 31 | 120 | $465,242 |
| 2023 | 5,331 | 33 | 228 | $577,052 |
| 2022 | 12,144 | 43 | 336 | $1,175,568 |
| 2021 | 6,262 | 36 | 233 | $869,656 |
| 2020 | 6,608 | 28 | 252 | $753,039 |
| 2019 | 10,865 | 38 | 362 | $1,141,794 |
| 2018 | 11,516 | 46 | 440 | $1,362,034 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,151 | $568,976 |
| Short return visit (20+ min) | 1,290 | $2,228 |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, mRNA-LNP, spike protein, 30 mcg/0.3 mL dosage, tris-sucrose formulation, for intramuscular use | 13 | $1,599 |
| Return visit (30+ min) | 324 | $1,037 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 21 | $693 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 72 | $387 |
| Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose | 12 | $300 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 259 | $287 |
| Hemoglobin A1C level | 105 | $250 |
| Short return visit | 116 | $218 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 57 | $188 |
| Blood test, lipids (cholesterol and triglycerides) | 58 | $186 |
2022
| Clinic visit/encounter, all-inclusive | 2,382 | $1,153,769 |
| Short return visit (20+ min) | 2,653 | $7,991 |
| Short return visit | 793 | $2,193 |
| Return visit (30+ min) | 683 | $2,036 |
| Pneumococcal conjugate vaccine, 20 valent (PCV20), for intramuscular use | 69 | $1,192 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 155 | $1,003 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 85 | $779 |
| Hemoglobin A1C level | 192 | $736 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 449 | $696 |
| Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use | 53 | $657 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 68 | $625 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 117 | $600 |
2021
| Clinic visit/encounter, all-inclusive | 1,804 | $861,401 |
| Short return visit (20+ min) | 993 | $2,990 |
| Short return visit | 937 | $2,136 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 108 | $758 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years) | 50 | $416 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 191 | $338 |
| Return visit (30+ min) | 147 | $296 |
| Hemoglobin A1C level | 79 | $209 |
| Blood test, lipids (cholesterol and triglycerides) | 78 | $193 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) | 135 | $190 |
| Thyroid stimulating hormone (TSH) | 38 | $151 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 13 | $121 |
2020
| Clinic visit/encounter, all-inclusive | 2,222 | $742,411 |
| Short return visit (20+ min) | 1,396 | $3,004 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 367 | $2,742 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 237 | $1,441 |
| Short return visit | 659 | $1,160 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 121 | $545 |
| Return visit (30+ min) | 168 | $436 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 80 | $284 |
| Pneumococcal conjugate vaccine, 13 valent (PCV13), for intramuscular use | 151 | $237 |
| Hemoglobin A1C level | 104 | $177 |
| Tuberculosis test, cell mediated immunity antigen response measurement; enumeration of gamma interferon-producing T-cells in cell suspension | 15 | $121 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 190 | $100 |
2019
| Clinic visit/encounter, all-inclusive | 3,405 | $1,124,649 |
| Short return visit (20+ min) | 2,633 | $8,777 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 263 | $1,979 |
| Return visit (30+ min) | 478 | $1,742 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 116 | $591 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 116 | $588 |
| Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use | 157 | $499 |
| Thyroid stimulating hormone (TSH) | 183 | $366 |
| Hemoglobin A1C level | 271 | $341 |
| Short return visit | 121 | $268 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 31 | $246 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 459 | $244 |
2018
| Clinic visit/encounter, all-inclusive | 4,073 | $1,338,502 |
| Short return visit (20+ min) | 2,189 | $10,403 |
| Return visit (30+ min) | 416 | $2,268 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; early childhood (age 1 through 4 years) | 215 | $1,635 |
| Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, amplified probe technique | 197 | $1,252 |
| Infectious agent detection by nucleic acid (DNA or RNA); Neisseria gonorrhoeae, amplified probe technique | 197 | $1,248 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; infant (age younger than 1 year) | 91 | $1,186 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 252 | $988 |
| Tuberculosis test, cell mediated immunity antigen response measurement; gamma interferon | 100 | $895 |
| Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; late childhood (age 5 through 11 years) | 80 | $521 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 50 | $357 |
| Hemoglobin A1C level | 326 | $351 |
Drugs they prescribed that Part D paid
$104,155
Pharmacies billed $104,155 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (36 of 706) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
596 generic and fewer than 11 brand-name prescriptions · $104,155 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 15 | $20,935 | $1,396 |
| Albuterol Sulfate Hfa | 11 | $478 | $43 |
| Hydrocodone-Acetaminophen | 21 | $452 | $22 |
| Duloxetine | 15 | $326 | $22 |
| Metformin | 30 | $259 | $9 |
See all 21 drugs
| Eliquis | 15 | $20,935 | $1,396 |
| Albuterol Sulfate Hfa | 11 | $478 | $43 |
| Hydrocodone-Acetaminophen | 21 | $452 | $22 |
| Duloxetine | 15 | $326 | $22 |
| Metformin | 30 | $259 | $9 |
| Diclofenac | 16 | $258 | $16 |
| Gabapentin | 16 | $234 | $15 |
| Metoprolol | 17 | $191 | $11 |
| Atorvastatin | 37 | $176 | $5 |
| Glipizide | 16 | $174 | $11 |
| Fluticasone Propionate | 19 | $162 | $9 |
| Levothyroxine | 16 | $121 | $8 |
| Losartan | 24 | $118 | $5 |
| Omeprazole | 19 | $109 | $6 |
| Pravastatin | 11 | $107 | $10 |
| Amlodipine Besylate | 37 | $102 | $3 |
| Ibuprofen | 13 | $80 | $6 |
| Famotidine | 12 | $41 | $3 |
| Furosemide | 13 | $40 | $3 |
| Zolpidem | 14 | $34 | $2 |
| Hydrochlorothiazide | 12 | $19 | $2 |
Year by year
| 2024 | 706 | 118 | 5% (36) | None | $104,155 |
| 2023 | 934 | 244 | 3% (27) | None | $141,080 |
| 2022 | 1,799 | 245 | 5% (84) | 16% | $253,732 |
| 2021 | 1,563 | 192 | 4% (57) | 17% | $173,475 |
| 2020 | 1,141 | 141 | 5% (52) | 23% | $154,916 |
| 2019 | 1,517 | 161 | 5% (77) | 18% | $141,591 |
| 2018 | 1,906 | 197 | 4% (83) | 19% | $159,113 |
| 2017 | 2,579 | 230 | 7% (183) | 19% | $172,178 |
| 2016 | 1,850 | 153 | 7% (137) | 19% | $121,800 |
| 2015 | 396 | 65 | 5% (21) | None | $18,731 |
| 2014 | 164 | 35 | 7% (12) | None | $3,985 |
| 2013 | 19 | None | 0% (0) | None | $767 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Atrovent Hfa | 13 | $7,454 | $573 |
| Metformin | 40 | $2,058 | $51 |
| Atorvastatin | 72 | $1,743 | $24 |
| Gabapentin | 34 | $1,040 | $31 |
| Omeprazole | 36 | $757 | $21 |
| Amlodipine Besylate | 42 | $679 | $16 |
| Levothyroxine | 31 | $572 | $18 |
| Famotidine | 11 | $432 | $39 |
| Fluticasone Propionate | 37 | $405 | $11 |
| Metoprolol | 18 | $378 | $21 |
| Losartan | 25 | $369 | $15 |
| Chlorthalidone | 11 | $363 | $33 |
| Pravastatin | 15 | $361 | $24 |
| Albuterol Sulfate Hfa | 11 | $357 | $32 |
| Fosinopril | 13 | $336 | $26 |
| Pregabalin | 11 | $258 | $23 |
| Sertraline | 14 | $245 | $17 |
| Lisinopril | 14 | $240 | $17 |
| Metoprolol | 15 | $219 | $15 |
| Furosemide | 16 | $168 | $11 |
| Alendronate | 11 | $125 | $11 |
| Clopidogrel | 11 | $118 | $11 |
| Ibuprofen | 12 | $97 | $8 |
| Hydrochlorothiazide | 11 | $53 | $5 |
2022: 53 drugs
| Trulicity | 30 | $44,336 | $1,478 |
| Novolog Flexpen | 18 | $18,692 | $1,038 |
| Victoza 2-Pak | 11 | $11,375 | $1,034 |
| Eliquis | 11 | $9,876 | $898 |
| Ozempic | 12 | $9,754 | $813 |
| Atrovent Hfa | 21 | $9,604 | $457 |
| Basaglar Kwikpen U-100 | 27 | $7,589 | $281 |
| Buprenorphine | 11 | $5,360 | $487 |
| Lantus Solostar | 11 | $3,414 | $310 |
| Flovent Hfa | 14 | $3,011 | $215 |
| Metformin | 61 | $2,710 | $44 |
| Gabapentin | 69 | $1,980 | $29 |
| Atorvastatin | 119 | $1,811 | $15 |
| Duloxetine | 19 | $1,506 | $79 |
| Ultra-Fine Nano Pen Needle | 14 | $1,352 | $97 |
| Levothyroxine | 52 | $1,317 | $25 |
| Ultra-Fine Short Pen Needle | 15 | $1,025 | $68 |
| Chlorthalidone | 30 | $886 | $30 |
| Fosinopril | 38 | $870 | $23 |
| Omeprazole | 71 | $826 | $12 |
| Metoprolol | 52 | $825 | $16 |
| Hydralazine | 27 | $671 | $25 |
| Baclofen | 43 | $648 | $15 |
| Pravastatin | 32 | $629 | $20 |
| Amlodipine Besylate | 75 | $594 | $8 |
| Methadone | 12 | $551 | $46 |
| Albuterol Sulfate Hfa | 12 | $483 | $40 |
| Fluticasone Propionate | 44 | $425 | $10 |
| Hydrocodone-Acetaminophen | 18 | $417 | $23 |
| Losartan | 54 | $410 | $8 |
| Fluoxetine | 11 | $405 | $37 |
| Metformin Hcl Er | 26 | $380 | $15 |
| Tamsulosin | 17 | $373 | $22 |
| Pregabalin | 14 | $356 | $25 |
| Lisinopril | 35 | $336 | $10 |
| Atenolol | 24 | $317 | $13 |
| Metoprolol | 19 | $279 | $15 |
| Propranolol | 13 | $219 | $17 |
| Trazodone | 15 | $219 | $15 |
| Triamcinolone Acetonide | 13 | $208 | $16 |
| Simvastatin | 13 | $189 | $15 |
| Famotidine | 16 | $187 | $12 |
| Hydrochlorothiazide | 32 | $174 | $5 |
| Pantoprazole | 12 | $152 | $13 |
| Furosemide | 17 | $138 | $8 |
| Donepezil | 12 | $136 | $11 |
| Sertraline | 18 | $129 | $7 |
| Alendronate | 15 | $128 | $9 |
| Clopidogrel | 11 | $105 | $10 |
| Glipizide | 11 | $100 | $9 |
| Benazepril | 13 | $97 | $7 |
| Ibuprofen | 11 | $65 | $6 |
| Tramadol | 17 | $44 | $3 |
2021: 45 drugs
| Trulicity | 30 | $34,244 | $1,141 |
| Novolog Flexpen | 25 | $19,598 | $784 |
| Basaglar Kwikpen U-100 | 25 | $8,668 | $347 |
| Bydureon Bcise | 11 | $8,589 | $781 |
| Buprenorphine | 15 | $5,845 | $390 |
| Atrovent Hfa | 14 | $5,823 | $416 |
| Lantus Solostar | 12 | $4,688 | $391 |
| Atorvastatin | 109 | $1,708 | $16 |
| Levothyroxine | 55 | $1,311 | $24 |
| Ultra-Fine Mini Pen Needle | 11 | $986 | $90 |
| Gabapentin | 53 | $942 | $18 |
| Chlorthalidone | 21 | $653 | $31 |
| Pravastatin | 38 | $617 | $16 |
| Methadone | 11 | $562 | $51 |
| Fosinopril | 31 | $536 | $17 |
| Metoprolol | 26 | $498 | $19 |
| Losartan | 46 | $475 | $10 |
| Amlodipine Besylate | 58 | $372 | $6 |
| Fluticasone Propionate | 30 | $362 | $12 |
| Baclofen | 29 | $341 | $12 |
| Atenolol | 22 | $330 | $15 |
| Omeprazole | 49 | $319 | $7 |
| Hydralazine | 26 | $315 | $12 |
| Metformin | 63 | $304 | $5 |
| Trazodone | 20 | $296 | $15 |
| Hydrocodone-Acetaminophen | 19 | $251 | $13 |
| Lisinopril | 47 | $250 | $5 |
| Mirtazapine | 17 | $228 | $13 |
| Metformin Hcl Er | 19 | $205 | $11 |
| Famotidine | 18 | $191 | $11 |
| Doxazosin Mesylate | 13 | $191 | $15 |
| Buspirone | 16 | $184 | $11 |
| Hydrochlorothiazide | 42 | $179 | $4 |
| Triamcinolone Acetonide | 13 | $169 | $13 |
| Tamsulosin | 19 | $152 | $8 |
| Fluoxetine | 14 | $142 | $10 |
| Finasteride | 12 | $126 | $11 |
| Furosemide | 23 | $123 | $5 |
| Metoprolol | 11 | $115 | $10 |
| Carvedilol | 12 | $97 | $8 |
| Simvastatin | 18 | $91 | $5 |
| Sertraline | 18 | $84 | $5 |
| Donepezil | 11 | $73 | $7 |
| Benazepril | 14 | $71 | $5 |
| Naproxen | 11 | $71 | $6 |
2020: 32 drugs
| Trulicity | 54 | $52,736 | $977 |
| Ozempic | 14 | $10,992 | $785 |
| Bydureon Bcise | 11 | $7,789 | $708 |
| Novolog Flexpen | 11 | $6,564 | $597 |
| Buprenorphine | 11 | $5,392 | $490 |
| Atrovent Hfa | 13 | $5,231 | $402 |
| Lantus Solostar | 12 | $4,841 | $403 |
| Basaglar Kwikpen U-100 | 13 | $4,238 | $326 |
| Levothyroxine | 49 | $1,275 | $26 |
| Atorvastatin | 71 | $762 | $11 |
| Ultra-Fine Mini Pen Needle | 12 | $701 | $58 |
| Pravastatin | 28 | $496 | $18 |
| Gabapentin | 34 | $436 | $13 |
| Hydralazine | 16 | $349 | $22 |
| Hydrocodone-Acetaminophen | 16 | $345 | $22 |
| Metformin | 43 | $306 | $7 |
| Losartan | 28 | $297 | $11 |
| Fluticasone Propionate | 25 | $280 | $11 |
| Amlodipine Besylate | 45 | $240 | $5 |
| Baclofen | 17 | $236 | $14 |
| Hydrochlorothiazide | 33 | $189 | $6 |
| Simvastatin | 19 | $176 | $9 |
| Omeprazole | 27 | $173 | $6 |
| Metformin Hcl Er | 18 | $169 | $9 |
| Lisinopril | 18 | $158 | $9 |
| Fluoxetine | 12 | $115 | $10 |
| Atenolol | 14 | $102 | $7 |
| Furosemide | 15 | $97 | $6 |
| Naproxen | 11 | $80 | $7 |
| Benazepril | 13 | $71 | $5 |
| Tamsulosin | 13 | $59 | $5 |
| Tramadol | 11 | $48 | $4 |
2019: 42 drugs
| Trulicity | 46 | $34,557 | $751 |
| Januvia | 11 | $8,262 | $751 |
| Ozempic | 11 | $8,208 | $746 |
| Lantus Solostar | 16 | $8,154 | $510 |
| Basaglar Kwikpen U-100 | 19 | $4,164 | $219 |
| Levothyroxine | 72 | $1,820 | $25 |
| Lidocaine | 13 | $1,521 | $117 |
| Atorvastatin | 103 | $1,371 | $13 |
| Ventolin Hfa | 17 | $1,014 | $60 |
| Ultra-Fine Mini Pen Needle | 16 | $810 | $51 |
| Gabapentin | 54 | $717 | $13 |
| Metformin | 79 | $610 | $8 |
| Metoprolol | 22 | $600 | $27 |
| Hydrocodone-Acetaminophen | 29 | $539 | $19 |
| Pravastatin | 24 | $525 | $22 |
| Fosinopril | 25 | $460 | $18 |
| Chlorthalidone | 13 | $414 | $32 |
| Losartan | 39 | $408 | $10 |
| Clopidogrel | 13 | $395 | $30 |
| Amlodipine Besylate | 48 | $361 | $8 |
| Hydralazine | 21 | $351 | $17 |
| Tamsulosin | 14 | $342 | $24 |
| Baclofen | 17 | $331 | $19 |
| Lisinopril | 32 | $319 | $10 |
| Trazodone | 19 | $295 | $16 |
| Omeprazole | 31 | $243 | $8 |
| Hydrochlorothiazide | 35 | $223 | $6 |
| Acetaminophen-Codeine | 21 | $217 | $10 |
| Ranitidine | 30 | $215 | $7 |
| Metoprolol | 17 | $203 | $12 |
| Fluticasone Propionate | 25 | $195 | $8 |
| Metformin Hcl Er | 24 | $194 | $8 |
| Simvastatin | 27 | $192 | $7 |
| Carvedilol | 15 | $183 | $12 |
| Atenolol | 13 | $179 | $14 |
| Montelukast | 16 | $172 | $11 |
| Benazepril | 16 | $160 | $10 |
| Furosemide | 26 | $152 | $6 |
| Fluoxetine | 14 | $148 | $11 |
| Naproxen | 15 | $134 | $9 |
| Methadone | 11 | $130 | $12 |
| Sertraline | 18 | $110 | $6 |
2018: 51 drugs
| Trulicity | 28 | $20,168 | $720 |
| Advair Diskus | 26 | $10,193 | $392 |
| Lantus Solostar | 18 | $9,655 | $536 |
| Tradjenta | 11 | $7,673 | $698 |
| Atrovent Hfa | 13 | $4,639 | $357 |
| Novolin 70-30 | 12 | $3,216 | $268 |
| Levothyroxine | 90 | $2,405 | $27 |
| Ezetimibe | 18 | $1,580 | $88 |
| Ventolin Hfa | 27 | $1,503 | $56 |
| Atorvastatin | 104 | $1,417 | $14 |
| Metoprolol | 39 | $1,031 | $26 |
| Gabapentin | 60 | $981 | $16 |
| Hydrocodone-Acetaminophen | 47 | $975 | $21 |
| Pravastatin | 34 | $867 | $26 |
| Ultra-Fine Mini Pen Needle | 18 | $855 | $48 |
| Chlorthalidone | 23 | $774 | $34 |
| Metformin | 92 | $741 | $8 |
| Isosorbide Dinitrate | 12 | $685 | $57 |
| Amlodipine Besylate | 93 | $670 | $7 |
| Fenofibrate | 15 | $640 | $43 |
| Baclofen | 22 | $551 | $25 |
| Tamsulosin | 27 | $497 | $18 |
| Voltaren | 12 | $477 | $40 |
| Fluticasone Propionate | 43 | $472 | $11 |
| Omeprazole | 54 | $445 | $8 |
| Fosinopril | 26 | $404 | $16 |
| Acetaminophen-Codeine | 23 | $357 | $16 |
| Fluoxetine | 13 | $301 | $23 |
| Lisinopril | 42 | $296 | $7 |
| Losartan | 32 | $273 | $9 |
| Ranitidine | 31 | $260 | $8 |
| Hydralazine | 12 | $246 | $20 |
| Hydrochlorothiazide | 38 | $206 | $5 |
| Atenolol | 14 | $202 | $14 |
| Methadone | 11 | $190 | $17 |
| Montelukast | 23 | $187 | $8 |
| Carvedilol | 18 | $182 | $10 |
| Simvastatin | 33 | $180 | $5 |
| Trazodone | 22 | $177 | $8 |
| Sertraline | 17 | $173 | $10 |
| Ibuprofen | 20 | $154 | $8 |
| Triamcinolone Acetonide | 11 | $141 | $13 |
| Furosemide | 30 | $133 | $4 |
| Clonidine | 14 | $131 | $9 |
| Metoprolol | 17 | $128 | $8 |
| Benazepril | 14 | $115 | $8 |
| Clopidogrel | 11 | $107 | $10 |
| Alendronate | 15 | $101 | $7 |
| Mupirocin | 14 | $95 | $7 |
| Pantoprazole | 11 | $83 | $8 |
| Naproxen | 13 | $81 | $6 |
2017: 63 drugs
| Trulicity | 30 | $17,946 | $598 |
| Advair Diskus | 27 | $8,666 | $321 |
| Lantus Solostar | 22 | $7,666 | $348 |
| Epipen 2-Pak | 12 | $6,847 | $571 |
| Spiriva | 12 | $5,272 | $439 |
| Chantix | 15 | $5,072 | $338 |
| Qvar | 25 | $4,666 | $187 |
| Flovent Hfa | 14 | $2,984 | $213 |
| Levothyroxine | 117 | $2,820 | $24 |
| Duloxetine | 21 | $2,366 | $113 |
| Ventolin Hfa | 36 | $1,941 | $54 |
| Lidocaine | 12 | $1,824 | $152 |
| Atorvastatin | 126 | $1,698 | $13 |
| Gabapentin | 114 | $1,636 | $14 |
| Hydrocodone-Acetaminophen | 89 | $1,553 | $17 |
| Fenofibrate | 18 | $1,314 | $73 |
| Fenofibrate | 23 | $1,182 | $51 |
| Chlorthalidone | 29 | $1,180 | $41 |
| Acetaminophen-Codeine | 62 | $1,143 | $18 |
| Omeprazole | 103 | $1,003 | $10 |
| Metoprolol | 43 | $943 | $22 |
| Isosorbide Dinitrate | 18 | $857 | $48 |
| Proair Hfa | 11 | $843 | $77 |
| Metformin | 96 | $808 | $8 |
| Pravastatin | 29 | $801 | $28 |
| Voltaren | 14 | $744 | $53 |
| Amlodipine Besylate | 103 | $626 | $6 |
| Fluticasone Propionate | 52 | $607 | $12 |
| Fluoxetine | 14 | $592 | $42 |
| Oxybutynin Chloride | 12 | $562 | $47 |
| Fosinopril | 43 | $533 | $12 |
| Baclofen | 24 | $442 | $18 |
| Atenolol | 40 | $368 | $9 |
| Sumatriptan | 14 | $366 | $26 |
| Methadone | 13 | $354 | $27 |
| Tamsulosin | 16 | $342 | $21 |
| Lisinopril | 53 | $316 | $6 |
| Clonidine | 24 | $307 | $13 |
| Simvastatin | 55 | $300 | $5 |
| Ranitidine | 37 | $284 | $8 |
| Sertraline | 30 | $278 | $9 |
| Losartan | 36 | $271 | $8 |
| Propranolol | 11 | $240 | $22 |
| Montelukast | 33 | $235 | $7 |
| Labetalol | 12 | $233 | $19 |
| Alendronate | 29 | $211 | $7 |
| Ibuprofen | 27 | $211 | $8 |
| Hydrochlorothiazide | 35 | $201 | $6 |
| Glipizide | 15 | $179 | $12 |
| Triamcinolone Acetonide | 13 | $176 | $14 |
| Metoprolol | 24 | $161 | $7 |
| Clopidogrel | 12 | $152 | $13 |
| Trazodone | 16 | $151 | $9 |
| Naproxen | 17 | $139 | $8 |
| Pantoprazole | 15 | $131 | $9 |
| Pramipexole Dihydrochloride | 11 | $107 | $10 |
| Benazepril | 17 | $104 | $6 |
| Cyclobenzaprine | 26 | $96 | $4 |
| Carisoprodol | 12 | $95 | $8 |
| Furosemide | 18 | $70 | $4 |
| Famotidine | 15 | $62 | $4 |
| Zolpidem | 16 | $41 | $3 |
| Lorazepam | 11 | $26 | $2 |
2016: 50 drugs
| Lantus Solostar | 21 | $11,392 | $542 |
| Zetia | 24 | $7,577 | $316 |
| Lidocaine | 11 | $7,258 | $660 |
| Qvar | 28 | $5,416 | $193 |
| Crestor | 11 | $3,550 | $323 |
| Diclofenac | 20 | $3,270 | $163 |
| Hydrocodone-Acetaminophen | 78 | $1,965 | $25 |
| Levothyroxine | 69 | $1,513 | $22 |
| Atorvastatin | 85 | $1,356 | $16 |
| Gabapentin | 102 | $1,144 | $11 |
| Fenofibrate | 21 | $984 | $47 |
| Ventolin Hfa | 19 | $975 | $51 |
| Isosorbide Dinitrate | 20 | $893 | $45 |
| Proair Hfa | 16 | $891 | $56 |
| Bd Ultra-Fine Pen Needle | 19 | $822 | $43 |
| Chlorthalidone | 20 | $821 | $41 |
| Duloxetine | 13 | $682 | $52 |
| Acetaminophen-Codeine | 32 | $592 | $18 |
| Metoprolol | 38 | $539 | $14 |
| Fosinopril | 36 | $538 | $15 |
| Omeprazole | 54 | $515 | $10 |
| Pravastatin | 27 | $499 | $18 |
| Methadone | 14 | $429 | $31 |
| Labetalol | 11 | $414 | $38 |
| Propranolol | 14 | $316 | $23 |
| Metformin | 54 | $313 | $6 |
| Amlodipine Besylate | 35 | $253 | $7 |
| Lisinopril | 59 | $243 | $4 |
| Tamsulosin | 15 | $243 | $16 |
| Hydrochlorothiazide | 47 | $240 | $5 |
| Alendronate | 17 | $239 | $14 |
| Clonidine | 21 | $237 | $11 |
| Pantoprazole | 20 | $204 | $10 |
| Fluticasone Propionate | 21 | $199 | $9 |
| Sertraline | 25 | $190 | $8 |
| Ranitidine | 29 | $189 | $7 |
| Simvastatin | 21 | $188 | $9 |
| Losartan | 24 | $188 | $8 |
| Atenolol | 24 | $186 | $8 |
| Hydralazine | 15 | $185 | $12 |
| Baclofen | 16 | $162 | $10 |
| Furosemide | 35 | $160 | $5 |
| Metoprolol | 20 | $146 | $7 |
| Trazodone | 21 | $141 | $7 |
| Ibuprofen | 20 | $108 | $5 |
| Metoclopramide | 16 | $84 | $5 |
| Montelukast | 12 | $76 | $6 |
| Zolpidem | 19 | $58 | $3 |
| Cyclobenzaprine | 13 | $55 | $4 |
| Lorazepam | 12 | $40 | $3 |
2015: 8 drugs
| Chlorthalidone | 11 | $401 | $36 |
| Atorvastatin | 21 | $331 | $16 |
| Metoprolol | 13 | $246 | $19 |
| Amlodipine Besylate | 23 | $210 | $9 |
| Gabapentin | 15 | $171 | $11 |
| Hydrocodone-Acetaminophen | 14 | $166 | $12 |
| Lisinopril | 22 | $103 | $5 |
| Omeprazole | 11 | $82 | $7 |
2014: 4 drugs
| Alendronate | 15 | $190 | $13 |
| Atorvastatin | 13 | $111 | $9 |
| Lisinopril | 11 | $87 | $8 |
| Hydrochlorothiazide | 15 | $74 | $5 |
Money from drug and device companies
$250 in 2019
A payment is not proof that care is biased.
| Amarin Pharma | Vascepa | $125 | 1 payment
|
| Merck Sharp & Dohme | Steglatro | $125 | 1 payment
|
See all 2 published payments
| Amarin Pharma | Meals · 2019-08-06 | Vascepa | $125 |
| Merck Sharp & Dohme | Meals · 2019-03-06 | Steglatro | $125 |
Professional record
- NPI
- 1972864882
- Licence
- CA A116162California A116162: Current · expires 2027-03-31
- Trained
- University of Hawaii John A. Burns School of Medicine, 2009
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 455 Oconnor Dr Ste 250, San Jose, CA, 95128
- NPI first listed
- 2012-06-06
- NPI last updated
- 2012-06-06
This is when the NPI record was last certified, not a medical board exam.